Literature DB >> 29302454

DNA methylation analysis for the treatment of meningiomas.

Julian L Gendreau1, Kevin K H Chow2, Eric S Sussman2, Aditya Iyer2, Arjun V Pendharkar2, Allen L Ho2.   

Abstract

Entities:  

Year:  2017        PMID: 29302454      PMCID: PMC5730532          DOI: 10.21037/jovs.2017.11.01

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


× No keyword cloud information.
  12 in total

1.  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.

Authors:  Felix Sahm; Daniel Schrimpf; Damian Stichel; David T W Jones; Thomas Hielscher; Sebastian Schefzyk; Konstantin Okonechnikov; Christian Koelsche; David E Reuss; David Capper; Dominik Sturm; Hans-Georg Wirsching; Anna Sophie Berghoff; Peter Baumgarten; Annekathrin Kratz; Kristin Huang; Annika K Wefers; Volker Hovestadt; Martin Sill; Hayley P Ellis; Kathreena M Kurian; Ali Fuat Okuducu; Christine Jungk; Katharina Drueschler; Matthias Schick; Melanie Bewerunge-Hudler; Christian Mawrin; Marcel Seiz-Rosenhagen; Ralf Ketter; Matthias Simon; Manfred Westphal; Katrin Lamszus; Albert Becker; Arend Koch; Jens Schittenhelm; Elisabeth J Rushing; V Peter Collins; Stefanie Brehmer; Lukas Chavez; Michael Platten; Daniel Hänggi; Andreas Unterberg; Werner Paulus; Wolfgang Wick; Stefan M Pfister; Michel Mittelbronn; Matthias Preusser; Christel Herold-Mende; Michael Weller; Andreas von Deimling
Journal:  Lancet Oncol       Date:  2017-03-15       Impact factor: 41.316

2.  Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.

Authors:  Pepijn van den Munckhof; Imke Christiaans; Susan B Kenter; Frank Baas; Theo J M Hulsebos
Journal:  Neurogenetics       Date:  2011-10-26       Impact factor: 2.660

3.  Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.

Authors:  Nina R Shah; Isabelle Tancioni; Kristy K Ward; Christine Lawson; Xiao Lei Chen; Christine Jean; Florian J Sulzmaier; Sean Uryu; Nichol L G Miller; Denise C Connolly; David D Schlaepfer
Journal:  Gynecol Oncol       Date:  2014-04-27       Impact factor: 5.482

4.  Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype.

Authors:  Mateusz Bujko; Marcin M Machnicki; Emilia Grecka; Nataliia Rusetska; Ewa Matyja; Paulina Kober; Tomasz Mandat; Małgorzata Rydzanicz; Rafał Płoski; Romuald Krajewski; Wieslaw Bonicki; Tomasz Stokłosa; Janusz A Siedlecki
Journal:  World Neurosurg       Date:  2016-10-15       Impact factor: 2.104

5.  Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.

Authors:  David E Reuss; Rosario M Piro; David T W Jones; Matthias Simon; Ralf Ketter; Marcel Kool; Albert Becker; Felix Sahm; Stefan Pusch; Jochen Meyer; Christian Hagenlocher; Leonille Schweizer; David Capper; Phillipp Kickingereder; Jana Mucha; Christian Koelsche; Natalie Jäger; Thomas Santarius; Patrick S Tarpey; Philip J Stephens; P Andrew Futreal; Ruth Wellenreuther; Jürgen Kraus; Doris Lenartz; Christel Herold-Mende; Christian Hartmann; Christian Mawrin; Nathalia Giese; Roland Eils; V Peter Collins; Rainer König; Otmar D Wiestler; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2013-02-12       Impact factor: 17.088

6.  Expression and gene doses changes of the p53-regulator PPM1D in meningiomas: a role in meningioma progression?

Authors:  Shinjiro Fukami; Markus J Riemenschneider; Michihiro Kohno; Hans Jakob Steiger
Journal:  Brain Tumor Pathol       Date:  2016-03-04       Impact factor: 3.298

7.  High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.

Authors:  Stéphane Goutagny; Jean C Nault; Maxime Mallet; Dominique Henin; Jessica Z Rossi; Michel Kalamarides
Journal:  Brain Pathol       Date:  2013-12-23       Impact factor: 6.508

8.  Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.

Authors:  Malak Abedalthagafi; Wenya Linda Bi; Ayal A Aizer; Parker H Merrill; Ryan Brewster; Pankaj K Agarwalla; Marc L Listewnik; Dora Dias-Santagata; Aaron R Thorner; Paul Van Hummelen; Priscilla K Brastianos; David A Reardon; Patrick Y Wen; Ossama Al-Mefty; Shakti H Ramkissoon; Rebecca D Folkerth; Keith L Ligon; Azra H Ligon; Brian M Alexander; Ian F Dunn; Rameen Beroukhim; Sandro Santagata
Journal:  Neuro Oncol       Date:  2016-01-28       Impact factor: 12.300

Review 9.  Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors.

Authors:  Tadas K Rimkus; Richard L Carpenter; Shadi Qasem; Michael Chan; Hui-Wen Lo
Journal:  Cancers (Basel)       Date:  2016-02-15       Impact factor: 6.639

Review 10.  EANO guidelines for the diagnosis and treatment of meningiomas.

Authors:  Roland Goldbrunner; Giuseppe Minniti; Matthias Preusser; Michael D Jenkinson; Kita Sallabanda; Emmanuel Houdart; Andreas von Deimling; Pantelis Stavrinou; Florence Lefranc; Morten Lund-Johansen; Elizabeth Cohen-Jonathan Moyal; Dieta Brandsma; Roger Henriksson; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2016-08-30       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.